Are beta-blockers safe and effective after myocardial infarction in patients with COPD?

Lindsay E Davis Elizabeth K Pogge Rajeev Garg

JAAPA

At the time this article was written, Lindsay E. Davis was a professor at Midwestern University College of Pharmacy in Glendale, Ariz. She is now a cardiology director in the internal medicine field medical group at Pfizer in Peoria, Ariz., and an adjunct professor at Midwestern University. Elizabeth K. Pogge is a professor at Midwestern University College of Pharmacy. Rajeev Garg is an interventional cardiologist at Heart One Associates in Phoenix, Ariz. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Published: March 2023

Clinicians may be hesitant to prescribe beta-blockers in patients with chronic obstructive pulmonary disease (COPD) who have a comorbid compelling cardiovascular indication for beta-blocker therapy. This article summarizes the available data on the safety and efficacy of beta-blockers in patients with COPD and recent myocardial infarction.

Download full-text PDF	Source
http://dx.doi.org/10.1097/01.JAA.0000918804.17000.75	DOI Listing

Publication Analysis

Top Keywords

myocardial infarction

beta-blockers patients

beta-blockers safe

safe effective

effective myocardial

infarction patients

patients copd?

copd? clinicians

clinicians hesitant

hesitant prescribe

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!